This week, we provide top-five ranked VE data for our Medical stocks. We take a look at our latest data on Intel $INTC. We currently have an overvaluation watch underway.
VALUATION WATCH: Overvalued stocks now make up 64.57% of our stocks assigned a valuation and 31.59% of those equities are calculated to be overvalued by 20% or more. Fifteen sectors are calculated to be overvalued.
ValuEngine Index Overview
| Index | Week Open | Friday AM | Change | % Change | YTD |
| DJIA | 20916.27 | 20694.72 | -221.55 | -1.06% | 4.72% |
| NASDAQ | 5898.81 | 5841.32 | -57.49 | -0.97% | 8.51% |
| RUSSELL 2000 | 1391.46 | 1353.43 | -38.03 | -2.73% | -0.27% |
| S&P 500 | 2378.24 | 2351.45 | -26.79 | -1.13% | 5.03% |
ValuEngine Market Overview
| Summary of VE Stock Universe | |
| Stocks Undervalued | 35.43% |
| Stocks Overvalued | 64.57% |
| Stocks Undervalued by 20% | 14.98% |
| Stocks Overvalued by 20% | 26.13% |
ValuEngine Sector Overview
| Sector | Change | MTD | YTD | Valuation | Last 12-MReturn | P/E Ratio |
| Multi-Sector Conglomerates | 0.57% | 1.51% | 6.23% | 17.25% overvalued | 14.12% | 20.16 |
| Computer and Technology | 0.29% | 1.11% | 7.85% | 16.63% overvalued | 23.30% | 31.30 |
| Industrial Products | 0.86% | -0.73% | 2.16% | 16.21% overvalued | 22.49% | 25.46 |
| Aerospace | 0.39% | -2.39% | 1.28% | 13.52% overvalued | 24.44% | 19.97 |
| Utilities | -0.02% | 1.09% | 2.57% | 12.29% overvalued | 20.04% | 23.08 |
| Finance | 0.47% | -2.13% | 1.79% | 10.89% overvalued | 17.76% | 17.48 |
| Construction | 0.39% | -0.49% | 6.88% | 10.20% overvalued | 23.29% | 21.34 |
| Business Services | 0.35% | -0.87% | 3.05% | 10.20% overvalued | 13.71% | 24.66 |
| Consumer Staples | 0.18% | 0.65% | 3.49% | 10.18% overvalued | 13.07% | 25.08 |
| Transportation | 0.24% | -3.04% | 2.24% | 7.16% overvalued | 14.95% | 19.16 |
| Auto-Tires-Trucks | 0.51% | -0.71% | 3.28% | 6.83% overvalued | 27.59% | 14.33 |
| Consumer Discretionary | 0.67% | 0.95% | 3.87% | 6.41% overvalued | 17.97% | 25.56 |
| Basic Materials | 0.07% | -2.20% | 5.73% | 4.90% overvalued | 47.77% | 26.81 |
| Medical | 0.31% | -1.99% | 7.99% | 1.74% overvalued | 13.99% | 27.69 |
| Retail-Wholesale | 0.51% | -1.15% | -1.01% | 1.74% overvalued | 4.12% | 23.48 |
| Oils-Energy | 0.34% | -4.74% | -4.58% | 2.16% undervalued | 17.67% | 30.11 |
Sector Talk–Medical
Below, we present the latest data on Medical stocks from our Professional Stock Analysis Service. Top- five lists are provided for each category. We applied some basic liquidity criteria–share price greater than $3 and average daily volume in excess of 100k shares.
Top-Five Medical Stocks–Short-Term Forecast Returns
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| EGRX | EAGLE PHARMACT | 81.83 | -6.51% | 97.51% |
| ANIP | ANI PHARMACEUT | 45.54 | -13.30% | 38.04% |
| LNTH | LANTHEUS HLDGS | 11.9 | N/A | 513.40% |
| LCI | LANNETT INC | 21.2 | -45.56% | 4.13% |
| SCMP | SUCAMPO PHARMAC | 10.75 | -30.84% | 6.02% |
Top-Five Medical Stocks–Momentum
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| AKAO | ACHOGEN INC | 20.3 | 223.89% | 574.42% |
| LNTH | LANTHEUS HLDGS | 11.9 | N/A | 513.40% |
| EXEL | EXELIXIS INC | 20.31 | 79.04% | 411.59% |
| CRBP | CORBUS PHARMACT | 9 | N/A | 381.28% |
| AERI | AERIE PHARMACT | 45.6 | 127.91% | 285.79% |
Top-Five Medical Stocks–Composite Score
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| EGRX | EAGLE PHARMACT | 81.83 | -6.51% | 97.51% |
| AZN | ASTRAZENECA PLC | 31.3 | 0.64% | 11.75% |
| HCA | HCA HOLDINGS | 83.17 | -10.34% | 8.08% |
| BIIB | BIOGEN INC | 275.41 | -17.61% | 7.90% |
| ANIP | ANI PHARMACEUT | 45.54 | -13.30% | 38.04% |
Top-Five Medical Stocks–Most Overvalued
| Ticker | Name | Mkt Price | Valuation (%) | Last 12-M Return (%) |
| ICPT | INTERCEPT PHARM | 115.8 | 300.00% | -5.59% |
| TSRO | TESARO INC | 153.62 | 269.32% | 233.59% |
| AKAO | ACHOGEN INC | 20.3 | 223.89% | 574.42% |
| DEPO | DEPOMED INC | 14.84 | 207.30% | 12.94% |
| CYH | COMMNTY HLTH SY | 8.7 | 195.72% | -51.04% |
Free Download for Readers
As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports
Intel Corporation (INTC) is one of the world’s largest semiconductor chip maker. The Company develops advanced integrated digital technology products, primarily integrated circuits, for industries such as computing and communications. It also develops platforms, which it defines as integrated suites of digital computing technologies that are designed and configured to work together to provide an optimized user computing solution compared to components that are used separately. Intel designs and manufactures computing and communications components, such as microprocessors, chipsets, motherboards, and wireless and wired connectivity products, as well as platforms that incorporate these components. The Company sells its products primarily to original equipment manufacturers, original design manufacturers, PC and network communications products users, and other manufacturers of industrial and communications equipment. Intel Corporation is based in Santa Clara, California.
VALUENGINE RECOMMENDATION: ValuEngine continues its BUY recommendation on INTEL CORP for 2017-03-23. Based on the information we have gathered and our resulting research, we feel that INTEL CORP has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Company Size and P/E Ratio.
You can download a free copy of detailed report on Intel Corporation (INTC) from the link below.
Read our Complete Rating and Forecast Report on Intel (INTC) HERE.
| ValuEngine Forecast | ||
| Target Price* |
Expected Return |
|
|---|---|---|
| 1-Month | 35.46 | 0.54% |
| 3-Month | 35.82 | 1.56% |
| 6-Month | 35.87 | 1.71% |
| 1-Year | 37.55 | 6.46% |
| 2-Year | 38.95 | 10.44% |
| 3-Year | 39.15 | 11.00% |
| Valuation & Rankings | |||
| Valuation | 6.80% overvalued | Valuation Rank(?) | 53 |
| 1-M Forecast Return | 0.54% | 1-M Forecast Return Rank | 86 |
| 12-M Return | 10.22% | Momentum Rank(?) | 45 |
| Sharpe Ratio | 0.29 | Sharpe Ratio Rank(?) | 68 |
| 5-Y Avg Annual Return | 5.95% | 5-Y Avg Annual Rtn Rank | 64 |
| Volatility | 20.41% | Volatility Rank(?) | 70 |
| Expected EPS Growth | -0.24% | EPS Growth Rank(?) | 21 |
| Market Cap (billions) | 170.53 | Size Rank | 100 |
| Trailing P/E Ratio | 12.63 | Trailing P/E Rank(?) | 86 |
| Forward P/E Ratio | 12.66 | Forward P/E Ratio Rank | 73 |
| PEG Ratio | n/a | PEG Ratio Rank | n/a |
| Price/Sales | 2.87 | Price/Sales Rank(?) | 37 |
| Market/Book | 4.00 | Market/Book Rank(?) | 32 |
| Beta | 1.03 | Beta Rank | 39 |
| Alpha | -0.01 | Alpha Rank | 43 |
ValuEngine.com is an Independent Research Provider (IRP), producing buy/hold/sell recommendations, target price, and valuations on over 5,000 US and Canadian equities every trading day.
Contact ValuEngine at (800) 381-5576 or support@valuengine.com
Visit www.ValuEngine.com for more information
ValuEngine Capital Management LLC is a Registered Investment Advisory (RIA) firm that trades client accounts using ValuENgine’s award-winning stock research.
Contact ValuEngine Capital at info@valuenginecapital.com
Visit www.ValuEngineCapital.com for more information